Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer

被引:72
作者
Rock, CL
Flatt, SW
Thomson, CA
Stefanick, ML
Newman, VA
Jones, LA
Natarajan, L
Ritenbaugh, C
Hollenbach, KA
Pierce, JP
Chang, RJ
机构
[1] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Canc Prevent & Control Program, La Jolla, CA 92093 USA
[4] Stanford Univ, Stanford Ctr Res Dis Prevent, Stanford, CA 94305 USA
[5] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[6] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Kaiser Permanente Ctr Hlth Res, Portland, OR USA
关键词
D O I
10.1200/JCO.2004.09.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Diet intervention trials are testing whether postdiagnosis dietary modification can influence breast cancer recurrence and survival. One possible mechanism is an effect on reproductive steroid hormones. Participants and Methods Serum reproductive steroid hormones were measured at enrollment and I year in 291 women with a history of breast cancer who were enrolled onto a randomized, controlled diet intervention trial. Dietary goals for the intervention group were increased fiber, vegetable, and fruit intakes and reduced fat intake. Estradiol, bioavailable estradiol, estrone, estrone sulfate, androstenedione, testosterone, dehydroepiandrosterone sulfate, follicle-stimulating hormone, and sex hormone-binding globulin were measured. Results The intervention (but not the comparison) group reported a significantly lower intake of energy from fat (21% v 28%), and higher intake of fiber (29 g/d v 22 g/d), at 1-year follow-up (P <.001). Significant weight loss did not occur in either group. A significant difference in the change in bioavailable estradiol concentration from baseline to 1 year in the intervention (- 13 pmol/L) versus the comparison (+3 pmol/L) group was observed (P <.05). Change in fiber (but not fat) intake was significantly and independently related to change in serum bioavailable estradiol (P <.01) and total estradiol (P <.05) concentrations. Conclusion Results from this study indicate that a high-fiber, low-fat diet intervention is associated with reduced serum bioavailable estradiol concentration in women diagnosed with breast cancer, the majority of whom did not exhibit weight loss. Increased fiber intake was independently related to the reduction in serum estradiol concentration. (C) 2004 by American Society of Clinical Oncology.
引用
收藏
页码:2379 / 2387
页数:9
相关论文
共 51 条
  • [11] Cohen LA, 1999, ANTICANCER RES, V19, P3685
  • [12] Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606
  • [13] Relation of energy, fat, and fiber intakes to plasma concentrations of estrogens and androgens in premenopausal women
    Dorgan, JF
    Reichman, ME
    Judd, JT
    Brown, C
    Longcope, C
    Schatzkin, A
    Forman, M
    Campbell, WS
    Franz, C
    Kahle, L
    Taylor, PR
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 64 (01) : 25 - 31
  • [14] Fowke JH, 2000, CANCER EPIDEM BIOMAR, V9, P773
  • [15] THE ROLE OF NUTRITION AND INSULIN IN THE REGULATION OF SEX-HORMONE BINDING GLOBULIN
    FRANKS, S
    KIDDY, DS
    HAMILTONFAIRLEY, D
    BUSH, A
    SHARP, PS
    REED, MJ
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 39 (5B) : 835 - 838
  • [16] Association of dietary factors and selected plasma variables with sex hormone-binding globulin in rural Chinese women
    Gates, JR
    Parpia, B
    Campbell, TC
    Junshi, C
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 63 (01) : 22 - 31
  • [17] Fibre and breast cancer
    Gerber, M
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 1998, 7 : S63 - S67
  • [18] A pharmacological review of selective oestrogen receptor modulators
    Goldstein, SR
    Siddhanti, S
    Ciaccia, AV
    Plouffe, L
    [J]. HUMAN REPRODUCTION UPDATE, 2000, 6 (03) : 212 - 224
  • [19] Aromatase inhibitors in the treatment and prevention of breast cancer
    Goss, PE
    Strasser, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) : 881 - 894
  • [20] Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer
    Harper-Wynne, CL
    Sacks, NPM
    Shenton, K
    MacNeill, FA
    Sauven, P
    Laidlaw, IJ
    Rayter, Z
    Miall, S
    Howes, A
    Salter, J
    Hills, MJ
    Lowe, FM
    A'Hern, R
    Nasiri, N
    Doody, D
    Iqbal, J
    Dowsett, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 1026 - 1035